文献速递神经重症与神经感染

妊娠期患者脑死亡判定中呼吸暂停试验的安全性

Safety of Apnea Testing in Pregnant Persons Undergoing Evaluation for Brain Death/Death by Neurologic Criteria.
PubMed 文献 · Neurology · 2025-08-14

2023年美国神经病学学会等指南指出妊娠并非脑死亡/神经学标准死亡(BD/DNC)判定的禁忌证,但呼吸暂停试验对胎儿的安全性尚不明确。专家小组进行范围综述,未发现直接评估该安全性的研究;间接证据提示高氧和高碳酸血症可能减少子宫胎盘血流、导致胎儿代谢性酸中毒及高碳酸血症诱导的脑过度灌注,若胎儿可能存活或需推迟呼吸暂停试验并考虑辅助检查。

要点

  • 妊娠不是BD/DNC判定的禁忌证,但呼吸暂停试验对胎儿的安全性未知。
  • 间接证据提示呼吸暂停试验相关高氧和高碳酸血症可能对胎儿有害。
  • 若胎儿可能存活,可考虑推迟呼吸暂停试验并采用辅助检查。

核心结论

  • 尚无研究直接评估妊娠期患者呼吸暂停试验对胎儿的安全性,间接证据提示可能存在不良影响。

研究设计与样本

  • 专家小组范围综述,涵盖BD/DNC、神经重症、母胎医学、新生儿科、胎儿/新生儿/儿童神经病学及儿科/胎儿麻醉学领域。

主要发现

  • 未发现直接评估呼吸暂停试验对胎儿安全性的研究。
  • 病例报告和系列中部分作者因安全顾虑明确避免呼吸暂停试验,但是否实施报告不一致。
  • 健康妊娠者及动物模型研究表明高氧和高碳酸血症可能导致子宫胎盘血流减少、胎儿代谢性酸中毒及高碳酸血症诱导的脑过度灌注。
  • 呼吸暂停试验中孕妇低血压或低氧血症也可能导致胎儿损伤。

关键数值与推荐

  • 2023年美国神经病学学会/美国儿科学会/儿童神经病学学会/重症医学学会指南指出妊娠不是BD/DNC判定的禁忌证。

临床怎么用

  • 若胎儿可能存活,应权衡是否推迟呼吸暂停试验。
  • 当其余BD/DNC评估和神经检查符合时,可使用放射性核素脑血流显像或经颅多普勒超声等辅助检查。

局限性

  • 缺乏直接评估妊娠期呼吸暂停试验胎儿安全性的研究。
  • 证据主要来自病例报告、系列及健康妊娠者和动物模型研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Brain death, or death by neurologic criteria (BD/DNC), is the permanent loss of brain function, defined by coma with loss of capacity for consciousness and complete brainstem areflexia, including the inability to breathe spontaneously. The 2023 American Academy of Neurology/American Academy of Pediatrics/Child Neurology Society (CNS)/Society for Critical Care Medicine guidelines state that pregnancy is not a contraindication for BD/DNC evaluation. Clinical evaluation of BD/DNC includes an apnea test to demonstrate the absence of spontaneous respiratory effort in response to hypercapnia and acidosis. The safety of apnea testing to the fetus in pregnant patients remains uncertain.We convened a panel of experts in BD/DNC, neurocritical care, maternal-fetal medicine, neonatology, fetal/neonatal/child neurology, and pediatric/fetal anesthesiology to perform a scoping review of apnea testing in pregnant persons. We found no studies directly assessing safety of apnea testing on the fetus. Apnea testing consists of fetal exposure to parental hyperoxia and hypercapnia; therefore, we searched for evidence related to these conditions in pregnancy. Case reports, series, and literature on physiologic changes induced during apnea testing and their potential effects on placental, fetal systemic, and fetal cerebral circulations were identified. In reported cases of BD/DNC in pregnant persons, some authors described explicitly avoiding apnea testing because of safety concerns, but whether apnea testing was performed at all was inconsistently reported. Evidence from studies evaluating hyperoxia and hypercapnia in healthy pregnant persons and in other animal models suggested possible adverse effects caused by reduced uteroplacental blood flow, fetal metabolic acidosis, and hypercapnia-induced cerebral hyperperfusion. Further possible complications of apnea testing, such as hypotension or hypoxemia in pregnant persons, could also contribute to fetal injury. These potential detrimental risks to the fetus raise the question as to whether apnea testing should be deferred if a fetus may be viable. Ancillary tests, such as radionuclide cerebral blood flow imaging or transcranial Doppler ultrasonography, can be used if the remainder of the BD/DNC evaluation and neurologic examination is otherwise consistent with BD/DNC. Further research is essential to assess the physiologic consequences of apnea testing in pregnant persons and potential risks to the fetus.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hyland A, Lewis A, Agarwal S, et al. Safety of Apnea Testing in Pregnant Persons Undergoing Evaluation for Brain Death/Death by Neurologic Criteria. Neurology. 2025. PMID: 40811756. doi:10.1212/WNL.0000000000214010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。